HP
Henry E. Pelish (Chief Scientific Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $3.3M of NUVL (33,994 sh across 4 lots, as filed), executed Mar 12. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.2M
shares × price, as filed
Last traded
Jul 9
Filed Jul 10
Median ADV $288.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
NUVLRecent filings
NUVLSALE
Nuvalent Inc
View filing →
$578K7,205 sh across 2 lots
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $863K
10,800 sh across 2 lots
Exec Jun 25 2025
Filed Jun 27 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $108K
1,343 sh × $80.54
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET